TP53 and endometrial cancer: Furthermore, a large Dutch nationwide cohort study revealed that BRCA1/2 carriers have a 2- to 3-fold increased risk for endometrial cancer, with the highest risk observed for the rare subgroups of serous-like and p53-abnormal endometrial cancer in BRCA1 carriers [93].